Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.29% |
| 2 | Consumer Discretionary | 17.84% |
| 3 | Financials | 13.34% |
| 4 | Healthcare | 12.27% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HT
201
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $72.3M | 0.07% |
3,368,449
-303,375
| -8% | -$6.05M |
|
202
Keurig Dr Pepper
KDP
$43.8B
| $72M | 0.07% |
590,541
+266,347
| +82% | +$32M |
|
203
Avient
AVNT
$4.1B
| $71.9M | 0.07% |
1,664,386
+13,378
| +0.8% | +$575K |
|
|
MFA
204
MFA Financial
MFA
$893M
| $71M | 0.07% |
2,340,173
-220,071
| -9% | -$6.73M |
|
205
Vodafone
VOD
$37.1B
| $70.6M | 0.07% |
2,904,953
+200,672
| +7% | +$5.47M |
|
206
Church & Dwight Co
CHD
$24B
| $70M | 0.07% |
1,316,849
-75,047
| -5% | -$3.63M |
|
207
Steven Madden
SHOO
$3.24B
| $69.6M | 0.07% |
1,967,403
+517,501
| +36% | +$17.3M |
|
208
Darling Ingredients
DAR
$10.1B
| $69.6M | 0.07% |
3,501,271
+203,992
| +6% | +$3.7M |
|
209
Exelixis
EXEL
$13.5B
| $68.7M | 0.07% |
3,194,242
-2,035,040
| -39% | -$42.1M |
|
210
Teladoc Health
TDOC
$1.18B
| $68.3M | 0.07% |
1,177,191
-440,317
| -27% | -$21.5M |
|
211
Moody's
MCO
$89.2B
| $66.9M | 0.07% |
392,053
+112,632
| +40% | +$19.1M |
|
212
Cintas
CTAS
$81.7B
| $66.8M | 0.07% |
1,444,000
+176,352
| +14% | +$7.94M |
|
213
JB Hunt Transport Services
JBHT
$24.5B
| $66.8M | 0.07% |
549,446
-30,654
| -5% | -$3.75M |
|
214
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
| $66.6M | 0.07% |
700,000
-300,000
| -30% | -$27.6M |
|
215
Rio Tinto
RIO
$168B
| $66.6M | 0.06% |
1,199,858
-443,388
| -27% | -$24.8M |
|
|
GWPH
216
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $66.4M | 0.06% |
475,833
-62,460
| -12% | -$8.87M |
|
|
FRC
217
DELISTED
First Republic Bank
FRC
| $66.4M | 0.06% |
685,692
-205,466
| -23% | -$19.8M |
|
|
PFPT
218
DELISTED
Proofpoint, Inc.
PFPT
| $66.4M | 0.06% |
575,544
+243,380
| +73% | +$29.6M |
|
219
Patterson-UTI
PTEN
$4.74B
| $66.1M | 0.06% |
3,674,357
-184,859
| -5% | -$3.71M |
|
220
Integra LifeSciences
IART
$1.31B
| $65.4M | 0.06% |
1,014,702
-141,648
| -12% | -$8.77M |
|
221
eBay
EBAY
$47B
| $65M | 0.06% |
1,793,865
+423,643
| +31% | +$16.5M |
|
222
Gaming and Leisure Properties
GLPI
$12.4B
| $65M | 0.06% |
1,815,040
+186,953
| +11% | +$6.48M |
|
223
Seacoast Banking Corp of Florida
SBCF
$3.33B
| $64.9M | 0.06% |
2,055,640
-17,881
| -0.9% | -$531K |
|
224
Boston Scientific
BSX
$67.9B
| $64.9M | 0.06% |
1,983,383
+35,833
| +2% | +$1.08M |
|
225
BP
BP
$109B
| $63.4M | 0.06% |
1,474,982
+361,605
| +32% | +$15.2M |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.91B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.